Low hepatic stearoyl-CoA desaturase 1 activity is associated with fatty liver and insulin resistance in obese humans

Diabetologia

Volumn 51, Issue 4, 2008, Pages 648-656

  Stefan, N ^a   Peter, A ^a   Cegan, A ^a   Staiger, H ^a   Machann, J ^a   Schick, F ^a   Claussen, C D ^a   Fritsche, A ^a   Haring H U ^a   Schleicher, E ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Diabetes; Fatty acid pattern; Fatty liver; Insulin resistance; Obesity; Prevention; Proton magnetic resonance spectroscopy; Stearoyl CoA desaturase 1; Thin layer chromatography; Very low density lipoprotein

Indexed keywords

ACYL COENZYME A DESATURASE; ACYL COENZYME A DESATURASE 1; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; VERY LOW DENSITY LIPOPROTEIN;

ADULT; AGED; ARTICLE; CORRELATION ANALYSIS; DIFFUSION WEIGHTED IMAGING; ENZYME ACTIVITY; EUGLYCEMIC HYPERINSULINEMIC CLAMP; FATTY LIVER; FEMALE; GAS CHROMATOGRAPHY; GLUCOSE METABOLISM; GLUCOSE TOLERANCE TEST; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIFESTYLE; LIPID METABOLISM; MAJOR CLINICAL STUDY; MALE; MATRICARIA; NUCLEAR MAGNETIC RESONANCE SCANNER; OBESITY; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; PROTECTION; PROTON NUCLEAR MAGNETIC RESONANCE; THIN LAYER CHROMATOGRAPHY; ULTRACENTRIFUGATION;

ADULT; AGED; BODY COMPOSITION; CHOLESTEROL, HDL; CHOLESTEROL, LDL; DIABETES MELLITUS, TYPE 2; FATTY LIVER; FEMALE; HUMANS; INSULIN; INSULIN RESISTANCE; LIVER; MALE; MIDDLE AGED; OBESITY; STEAROYL-COA DESATURASE; WEIGHT LOSS;

EID: 41149102818     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00125-008-0938-7     Document Type: Article

References (50)

1. Angulo P (2002) Nonalcoholic fatty liver disease. N Engl J Med 346:1221-1231
2. Kelley DE, McKolanis TM, Hegazi RA, Kuller LH, Kalhan SC (2003) Fatty liver in type 2 diabetes mellitus: relation to regional adiposity, fatty acids, and insulin resistance. Am J Physiol Endocrinol Metab 285:E906-E916
3. Marchesini G, Babini M (2006) Nonalcoholic fatty liver disease and the metabolic syndrome. Minerva Cardioangiol 54:229-239
4. Petersen KF, Dufour S, Feng J et al (2006) Increased prevalence of insulin resistance and nonalcoholic fatty liver disease in Asian-Indian men. Proc Natl Acad Sci U S A 103:18273-18277
5. Roden M (2006) Mechanisms of disease: hepatic steatosis in type 2 diabetes-pathogenesis and clinical relevance. Nat Clin Pract Endocrinol Metab 2:335-348
6. Targher G, Bertolini L, Poli F et al (2005) Nonalcoholic fatty liver disease and risk of future cardiovascular events among type 2 diabetic patients. Diabetes 54:3541-3546
7. Utzschneider KM, Kahn SE (2006) Review: The role of insulin resistance in nonalcoholic fatty liver disease. J Clin Endocrinol Metab 91:4753-4761
8. Bugianesi E, Pagotto U, Manini R et al (2005) Plasma adiponectin in nonalcoholic fatty liver is related to hepatic insulin resistance and hepatic fat content, not to liver disease severity. J Clin Endocrinol Metab 90:3498-3504
9. Kantartzis K, Rittig K, Balletshofer B et al (2006) The relationships of plasma adiponectin with a favorable lipid profile, decreased inflammation, and less ectopic fat accumulation depend on adiposity. Clin Chem 52:1934-1942
10. Stefan N, Machicao F, Staiger H et al (2005) Polymorphisms in the gene encoding adiponectin receptor 1 are associated with insulin resistance and high liver fat. Diabetologia 48:2282-2291
11. Kantartzis K, Fritsche A, Machicao F et al (2007) Upstream transcription factor 1 gene polymorphisms are associated with high antilipolytic insulin sensitivity and show gene-gene interactions. J Mol Med 85:55-61
12. Donnelly KL, Smith CI, Schwarzenberg SJ, Jessurun J, Boldt MD, Parks EJ (2005) Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease. J Clin Invest 115:1343-1351
13. Westerbacka J, Lammi K, Hakkinen AM et al (2005) Dietary fat content modifies liver fat in overweight nondiabetic subjects. J Clin Endocrinol Metab 90:2804-2809
14. Tiikkainen M, Bergholm R, Vehkavaara S et al (2003) Effects of identical weight loss on body composition and features of insulin resistance in obese women with high and low liver fat content. Diabetes 52:701-707
15. Hudgins LC, Hellerstein M, Seidman C, Neese R, Diakun J, Hirsch J (1996) Human fatty acid synthesis is stimulated by a eucaloric low fat, high carbohydrate diet. J Clin Invest 97:2081-2091
16. Ueki K, Kadowaki T, Kahn CR (2005) Role of suppressors of cytokine signaling SOCS-1 and SOCS-3 in hepatic steatosis and the metabolic syndrome. Hepatol Res 33:185-192
17. Taskinen MR (2003) Diabetic dyslipidaemia: from basic research to clinical practice. Diabetologia 46:733-749
18. Miyazaki M, Kim YC, Ntambi JM (2001) A lipogenic diet in mice with a disruption of the stearoyl-CoA desaturase 1 gene reveals a stringent requirement of endogenous monounsaturated fatty acids for triglyceride synthesis. J Lipid Res 42:1018-1024
19. Jones BH, Maher MA, Banz WJ et al (1996) Adipose tissue stearoyl-CoA desaturase mRNA is increased by obesity and decreased by polyunsaturated fatty acids. Am J Physiol 271:E44-E49
20. Pan DA, Lillioja S, Milner MR et al (1995) Skeletal muscle membrane lipid composition is related to adiposity and insulin action. J Clin Invest 96:2802-2808
21. Storlien LH, Jenkins AB, Chisholm DJ, Pascoe WS, Khouri S, Kraegen EW (1991) Influence of dietary fat composition on development of insulin resistance in rats. Relationship to muscle triglyceride and omega-3 fatty acids in muscle phospholipid. Diabetes 40:280-289
22. Vessby B, Aro A, Skarfors E, Berglund L, Salminen I, Lithell H (1994) The risk to develop NIDDM is related to the fatty acid composition of the serum cholesterol esters. Diabetes 43:1353-1357
23. Warensjo E, Riserus U, Vessby B (2005) Fatty acid composition of serum lipids predicts the development of the metabolic syndrome in men. Diabetologia 48:1999-2005
24. Ntambi JM, Miyazaki M, Stoehr JP et al (2002) Loss of stearoyl-CoA desaturase-1 function protects mice against adiposity. Proc Natl Acad Sci U S A 99:11482-11486
25. Cohen P, Miyazaki M, Socci ND et al (2002) Role for stearoyl-CoA desaturase-1 in leptin-mediated weight loss. Science 297:240-243
26. Dobrzyn P, Dobrzyn A, Miyazaki M et al (2004) Stearoyl-CoA desaturase 1 deficiency increases fatty acid oxidation by activating AMP-activated protein kinase in liver. Proc Natl Acad Sci U S A 101:6409-6414
27. Flowers MT, Groen AK, Oler AT et al (2006) Cholestasis and hypercholesterolemia in SCD1-deficient mice fed a low-fat, high-carbohydrate diet. J Lipid Res 47:2668-2680
28. Gutierrez-Juarez R, Pocai A, Mulas C et al (2006) Critical role of stearoyl-CoA desaturase-1 (SCD1) in the onset of diet-induced hepatic insulin resistance. J Clin Invest 116:1686-1695
29. Miyazaki M, Flowers MT, Sampath H et al (2007) Hepatic stearoyl-CoA desaturase-1 deficiency protects mice from carbohydrate-induced adiposity and hepatic steatosis. Cell Metab 6:484-496
30. Machann J, Thamer C, Schnoedt B et al (2005) Standardized assessment of whole body adipose tissue topography by MRI. J Magn Reson Imaging 21:455-462
31. Szczepaniak LS, Nurenberg P, Leonard D et al (2005) Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population. Am J Physiol Endocrinol Metab 288:E462-E468
32. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (1997) Report of the Expert Committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 20:1183-1197
33. Matsuda M, DeFronzo RA (1999) Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 22:1462-1470
34. Stefan N, Wahl HG, Fritsche A, Haring H, Stumvoll M (2001) Effect of the pattern of elevated free fatty acids on insulin sensitivity and insulin secretion in healthy humans. Horm Metab Res 33:432-438
35. Kim YC, Gomez FE, Fox BG, Ntambi JM (2000) Differential regulation of the stearoyl-CoA desaturase genes by thiazolidinediones in 3T3-L1 adipocytes. J Lipid Res 41:1310-1316
36. Vessby B, Gustafsson IB, Tengblad S, Boberg M, Andersson A (2002) Desaturation and elongation of fatty acids and insulin action. Ann NY Acad Sci 967:183-195
37. Meyer C, Pimenta W, Woerle HJ et al (2006) Different mechanisms for impaired fasting glucose and impaired postprandial glucose tolerance in humans. Diabetes Care 29:1909-1914
38. Stefan N, Hennige AM, Staiger H et al (2006) Alpha2-Heremans-Schmid glycoprotein/fetuin-A is associated with insulin resistance and fat accumulation in the liver in humans. Diabetes Care 29:853-857
39. Houdali B, Wahl HG, Kresi M et al (2003) Glucose oversupply increases Delta9-desaturase expression and its metabolites in rat skeletal muscle. Diabetologia 46:203-212
40. Pinnamaneni SK, Southgate RJ, Febbraio MA, Watt MJ (2006) Stearoyl CoA desaturase 1 is elevated in obesity but protects against fatty acid-induced skeletal muscle insulin resistance in vitro. Diabetologia 49:3027-3037
41. Dobrzyn A, Ntambi JM (2005) Stearoyl-CoA desaturase as a new drug target for obesity treatment. Obes Rev 6:169-174
42. Rahman SM, Dobrzyn A, Dobrzyn P, Lee SH, Miyazaki M, Ntambi JM (2003) Stearoyl-CoA desaturase 1 deficiency elevates insulin-signaling components and down-regulates protein-tyrosine phosphatase 1B in muscle. Proc Natl Acad Sci U S A 100:11110-11115
43. Toye AA, Dumas ME, Blancher C et al (2007) Subtle metabolic and liver gene transcriptional changes underlie diet-induced fatty liver susceptibility in insulin-resistant mice. Diabetologia 50:1867-1879
44. Miyazaki M, Dobrzyn A, Elias PM, Ntambi JM (2005) Stearoyl-CoA desaturase-2 gene expression is required for lipid synthesis during early skin and liver development. Proc Natl Acad Sci U S A 102:12501-12506
45. Binczek E, Jenke B, Holz B, Gunter RH, Thevis M, Stoffel W (2007) Obesity resistance of the stearoyl-CoA desaturase-deficient (scd1-/-) mouse results from disruption of the epidermal lipid barrier and adaptive thermoregulation. Biol Chem 388:405-418
46. Legrand P, Catheline D, Fichot MC, Lemarchal P (1997) Inhibiting delta9-desaturase activity impairs triacylglycerol secretion in cultured chicken hepatocytes. J Nutr 127:249-256
47. Man WC, Miyazaki M, Chu K, Ntambi J (2006) Colocalization of SCD1 and DGAT2: implying preference for endogenous monounsaturated fatty acids in triglyceride synthesis. J Lipid Res 47:1928-1939
48. Flowers JB, Rabaglia ME, Schueler KL et al (2007) Loss of stearoyl-CoA desaturase-1 improves insulin sensitivity in lean mice but worsens diabetes in leptin-deficient obese mice. Diabetes 56:1228-1239
49. Busch AK, Gurisik E, Cordery DV et al (2005) Increased fatty acid desaturation and enhanced expression of stearoyl coenzyme A desaturase protects pancreatic beta-cells from lipoapoptosis. Diabetes 54:2917-2924
50. Riserus U, Tan GD, Fielding BA et al (2005) Rosiglitazone increases indexes of stearoyl-CoA desaturase activity in humans: link to insulin sensitization and the role of dominant-negative mutation in peroxisome proliferator-activated receptor-gamma. Diabetes 54:1379-1384